Výsledky vyhledávání

Modified CAPOX (Capecitabine plus Oxaliplatin) Regimen Every Two Weeks as Second-Line Treatment in Patients with Advanced Colorectal Cancer Previously Treated with Irinotecan-Based Frontline Therapy

Autor: S. Tsousis, Athanasios Athanasiadis, K. Amarantidis, John Souglakos, L. Vamvakas, Alexandros Ardavanis, Ioannis Varthalitis, Nikolaos Ziras, S. Kakolyris, V. Georgoulias, N. Vardakis, Aristidis Polyzos

Publikováno v: Oncology. 74:31-36

Background: To evaluate the efficacy and tolerance of capecitabine (CAP) given every other week and biweekly oxaliplatin (OX; modified CAPOX regimen) in patients with advanced colorectal cancer previously treated with irinote- can-based frontline che

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::6e08341abf77f097cc1abe10dcbc8df1
https://doi.org/10.1159/000138977

Zobrazit plný text záznamu

A phase II study of ondansetron as antiemetic prophylaxis in patients receiving high-dose polychemotherapy and stem cell transplantation

Autor: George Koumakis, H. Hatzichristou, Anna Efremidis, S. Tsousis, V. Barbounis, M. Vassilomanolakis

Publikováno v: Supportive Care in Cancer. 3:301-306

The field of high-dose chemotherapy with stem cell transplantation has been expanded recently as a treatment for solid tumors and hematological malignancies. Severe emesis remains one of the main extramedullary side-effects of high-dose regimens duri

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2ec27a21ffac0351ccd434092cc5e9e3
https://doi.org/10.1007/bf00335306

Zobrazit plný text záznamu

Modified CAPOX (capecitabine plus oxaliplatin) regimen every two weeks as second-line treatment in patients with advanced colorectal cancer previously treated with irinotecan-based frontline therapy: a multicenter phase II study

Autor: S, Kakolyris, J, Souglakos, A, Polyzos, A, Ardavanis, N, Ziras, A, Athanasiadis, I, Varthalitis, K, Amarantidis, S, Tsousis, L, Vamvakas, N, Vardakis, V, Georgoulias

Publikováno v: Oncology. 74(1-2)

To evaluate the efficacy and tolerance of capecitabine (CAP) given every other week and biweekly oxaliplatin (OX; modified CAPOX regimen) in patients with advanced colorectal cancer previously treated with irinote- can-based frontline chemotherapy.Si

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::cc00caa65b482d4b5c7460e494035d4e
https://pubmed.ncbi.nlm.nih.gov/18544957

Zobrazit plný text záznamu

Multicenter phase II study of gemcitabine and oxaliplatin (GEMOX) as second-line chemotherapy in colorectal cancer patients pretreated with 5-fluorouracil plus irinotecan

Autor: C Christofillakis, Anna Potamianou, Ioannis Varthalitis, Kostas N. Syrigos, E. Tselepatiotis, V. Georgoulias, Nikolaos Ziras, S. Tsousis, I. Boukovinas

Publikováno v: Oncology. 70(2)

Purpose: To evaluate the efficacy and tolerance of the gemcitabine/oxaliplatin (GEMOX) combination as second-line chemotherapy for patients with advanced colorectal cancer (CRC) pretreated with an irinotecan (CPT-11)/5-fluorouracil (5-FU)/leucovorin

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::60e038ea52b8fd964af491dc85eaf0fa
https://pubmed.ncbi.nlm.nih.gov/16645323

Zobrazit plný text záznamu

A phase II study of flutamide in ovarian cancer

Autor: V. Barbounis, H Hajichristou, M. Vassilomanolakis, George Koumakis, S. Tsousis, A. P. Efremidis

Publikováno v: Oncology. 54(3)

A phase II study of flutamide was conducted in 24 patients with stage III and IV ovarian cancer who failed chemotherapy and who had measurable disease. Flutamide was administered at a dose of 100 mg three times daily continuously until evidence of pr

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::35877c103fa510ff85094577974d701e
https://pubmed.ncbi.nlm.nih.gov/9143399

Zobrazit plný text záznamu

Sources of discrepancies in the diagnosis of Hodgkin's disease by fine needle aspiration

Autor: D, Daskalopoulou, D, Tamiolakis, S, Tsousis, N, Apostolikas, S, Markidou

Publikováno v: Archives d'anatomie et de cytologie pathologiques. 44(4)

The aim of this study was to assess the value of Fine Needle Aspiration (FNA) Cytology in the diagnosis of Hodgkin's Disease (HD) and to identify the sources and nature of the inaccuracies related to this procedure. We retrospectively studied all cas

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::619cf63a6aafec624707d8e1a13c2b34
https://pubmed.ncbi.nlm.nih.gov/9157825

Zobrazit plný text záznamu

242 Preventive versus therapeutic use of G-CSF following high dose cyclophosphamide (H.D.CTX)

Autor: S. Tsousis, M. Vilssilomanolakis, H. Hatzichristou, V. Barbounis, Anna Efremidis, George Koumakis

Publikováno v: European Journal of Cancer. 31:S53

The preventive vs therapeutic administration schedules of G-CSF is under study in this trial. Thirty-eight patients with advanced malignancies received CTX 4.5 gr/m2 and equal dose of Mesna divided in two days. The pts were randomized to receive G-CS

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::653a33d9795924feb83ca0010c6fe389
https://doi.org/10.1016/0959-8049(95)95500-6

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání